Cardiovascular disease – Third annual audit report (CVDPREVENT)
The CVDPREVENT Audit has published its third annual audit report. Covering the audit period up to March 2022, it provides insight into the impact of the COVID-19 pandemic on primary care services (diagnosis and management of hypertension were significantly disrupted) and compares the national position against key ambitions identified as milestones for the prevention of CVD; the detection and management of atrial fibrillation, blood pressure and cholesterol.
Key findings include:
- The prevalence of cardiovascular disease in adults in England was 6.0%. The prevalence increased with age and males were more likely than females to have the disease
- Prescription of anticoagulation drug therapy, for those with AF at high-risk of stroke, increased by one percentage point since March 2021 to 88.9% in March 2022
- Nearly 20% of people with CVD did not have a recorded current prescription of lipid lowering therapy (secondary prevention).
This report also includes findings relating to diagnoses of chronic kidney disease and diabetes; lifestyle; and health inequalities, as well as a number of recommendations to support the prevention of cardiovascular disease.
Read the full report: You can read the report by clicking on the link below.
Stay up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.
